CD133 selected stem cells from proliferating infantile hemangioma and establishment of an in vivo mice model of hemangioma

Chinese Medical Journal

Volumn 126, Issue 1, 2013, Pages 88-94

  Mai, Hua Ming ^a,b   Zheng, Jia Wei ^a,b   Wang, Yan An ^a,b   Yang, Xiu Juan ^a,b   Zhou, Qin ^a,b   Qin, Zhong Ping ^c   Li, Ke Lei ^c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c LINYI CANCER HOSPITAL   (China)

Author keywords

Hemangioma; Model; Stem cell; Vascularization

Indexed keywords

BETA1 INTEGRIN; CD133 ANTIGEN; CD31 ANTIGEN; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; GLUCOSE TRANSPORTER 1; HERMES ANTIGEN; INTERSTITIAL COLLAGENASE; MATRIGEL; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CAPILLARY DENSITY; CAPILLARY HEMANGIOMA; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SELECTION; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PHASE CONTRAST MICROSCOPY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; STEM CELL; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; GLYCOPROTEINS; HEMANGIOMA; HUMANS; LAMININ; MALE; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; PEPTIDES; PROTEOGLYCANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874388591     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121141     Document Type: Article

References (32)

1. Boscolo E, Bischoff J. Vasculogenesis in infantile hemangioma. Angiogenesis 2009; 12: 197-207.
2. Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol 2011; 25: 1245-1253.
3. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118: 882-887.
4. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
5. Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008; 118: 2592-2599.
6. Yu Y, Fuhr J, Boye E, Gyorffy S, Soker S, Atala A, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006; 24: 1605-1612.
7. Itinteang T, Vishvanath A, Day DJ, Tan ST. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol 2011; 64: 232-236.
8. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, et al. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006; 108: 915-921.
9. Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials 2010; 31: 8198-8209.
10. Zhou Z, Stewart KS, Yu L, Kleinerman ES. Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung. Angiogenesis 2011; 14: 125-133.
11. Song M, Xiao C, Wang T, Pei Q, Wang S, Xu L, et al. Study of the differentially expressed genes in pleomorphic adenoma using cDNA microarrays. Pathol Oncol Res 2011; 17: 765-769.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
13. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 1991; 324: 1-8.
14. Yuan SM, Chen RL, Shen WM, Chen HN, Zhou XJ. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatr Dev Pathol 2011; 15: 5-12
15. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
16. Aslan H, Zilberman Y, Kandel L, Liebergall M, Oskouian RJ, Gazit D, et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 2006; 24: 1728-1737.
17. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, Fish RJ, et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 2007; 5: 826-834.
18. Martins AA, Paiva A, Morgado JM, Gomes A, Pais ML. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc 2009; 41: 943-946.
19. Jenhani F, Durand V, Ben AN, Thallet S, Ben Othmen T, Bejaoui M. Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transplant Proc 2011; 43: 639-643.
20. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, et al. Identification of the anti-angiogenic site within vascular basement membranederived tumstatin. J Biol Chem 2001; 276: 15240-15248.
21. Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 2006; 103: 855-860.
22. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006; 66: 10357-10364
23. Holland KE, Drolet BA. Infantile hemangioma. Pediatr Clin North Am 2010; 57: 1069-1083.
24. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010; 362: 1005-1013.
25. Raza A, Franklin MJ, Dudek AZ. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 2010; 85: 593-598.
26. Boscolo E, Mulliken JB, Bischoff J. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 2011; 31: 2181-2192.
27. Mancini AJ, Smoller BR. Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 1996; 18: 505-514.
28. Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 2007; 25: 1761-1768.
29. Liekens S, Andrei G, Vandeputte M, De Clercq E, Neyts J. Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir. Cancer Res 1998; 58: 2562-2567.
30. Kitajima S, Liu E, Morimoto M, Koike T, Yu Y, Watanabe T, et al. Transgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach-Merritt syndrome. Lab Invest 2005; 85: 1517-1527.
31. Tang Y, Liu W, Yu S, Wang Y, Peng Q, Xiong Z, et al. A novel in vivo model of human hemangioma: xenograft of human hemangioma tissue on nude mice. Plast Reconstr Surg 2007; 120: 869-878.
32. Tan ST, Hasan Q, Velickovic M, Rüger BM, Davis RP, Davis PF. A novel in vitro human model of hemangioma. Mod Pathol 2000; 13: 92-99.